Cargando…

Venlafaxine extended release (XR) in the treatment of panic disorder

Panic disorder is a chronic, recurrent illness, with a lifetime prevalence of about 5%. It is associated with substantial functional impairment, and studies suggest that treatment with medication alone (and no instruction in exposure to feared and avoided situations) is less than optimal. In fact, 4...

Descripción completa

Detalles Bibliográficos
Autores principales: Kjernisted, Kevin, McIntosh, Diane
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1936289/
https://www.ncbi.nlm.nih.gov/pubmed/18360616